Family Medicine · Las Vegas, NV
NPI
1376767673
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3201 S Maryland Pkwy Ste 218
Las Vegas, NV, 89109
Phone (702) 862-8075
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
452 services
Medicare patients, 2024
82
Average age 62
Drug cost, 2024
$6.0M
8,075 prescriptions
Company payments, 2025
$28K
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Warren W Magnus was code 99214 (office e&m - established), 263 times for 77 patients. In total Warren W Magnus billed 452 services in 23 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 263 | 77 | $81.71 | $21K |
| 96372 Injection Administration | Office | 61 | 12 | $11.29 | $689 |
| 99213 Office E&M - Established | Office | 24 | 17 | $64.42 | $1,546 |
| G0008 Administration of influenza virus vaccine | Office | 12 | 12 | $29.40 | $353 |
By year: 2022 $23K for 434 services; 2023 $22K for 630 services; 2024 $28K for 452 services.
Medicare prescription drug claims, 2024
In 2024, the drug Warren W Magnus prescribed most often to Medicare patients was Rosuvastatin Calcium, with 380 prescriptions and refills. In total Warren W Magnus wrote 8,075 Medicare prescriptions that cost $6.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 380 | 434 | 51 | $1,397 |
| Dovato Dolutegravir Sodium/Lamivudine | 375 | 381 | 40 | $1.1M |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 311 | 311 | 35 | $1.2M |
| Atorvastatin Calcium Generic | 297 | 323 | 36 | $787 |
| Tivicay Dolutegravir Sodium | 244 | 244 | 27 | $547K |
| Tamsulosin Hcl Generic | 239 | 267 | 27 | $692 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 211 | 211 | 31 | $5,418 |
| Testosterone Generic | 186 | 190 | 23 | $24K |
| Gabapentin Generic | 177 | 193 | 22 | $1,449 |
| Omeprazole Generic | 167 | 181 | 21 | $686 |
| Juluca Dolutegravir/Rilpivirine | 160 | 160 | 15 | $550K |
| Descovy Emtricitabine/Tenofov Alafenam | 160 | 160 | 18 | $350K |
| Losartan Potassium Generic | 156 | 218 | 26 | $377 |
| Amlodipine Besylate Generic | 141 | 151 | 19 | $198 |
| Testosterone Cypionate Generic | 137 | 144 | 17 | $4,530 |
Brand drugs: 2,718 claims; generic drugs: 5,306 claims; opioid claims: 59.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Warren W Magnus $28K ($28K in general payments such as food, travel and fees) from 3 companies. The largest payer was ViiV Healthcare Company with $28K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.